Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism

American Journal of Pathology

Volumn 161, Issue 4, 2002, Pages 1299-1306

  Dwight, Trisha ^a,b,c   Nelson, Anne E ^a,c   Theodosopoulos, George ^a   Richardson, Anne Louise ^a   Learoyd, Diana L ^a,c   Philips, Jeanette ^d   Delbridge, Leigh ^d   Zedenius, Jan ^b   Teh, Bin T ^e   Larsson, Catharina ^b   Marsh, Deborah J ^a,c   Robinson, Bruce G ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR;

ADULT; ALLELE; ARTICLE; CANCER SURGERY; CARCINOGENESIS; CHROMOSOME; CHROMOSOME MOSAICISM; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE LOSS; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; HEREDITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MEN1 GENE; MOLECULAR GENETICS; MULTIPLE CANCER; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID TUMOR; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RECEPTOR GENE; SOMATIC MUTATION;

EID: 0036792489     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64406-9     Document Type: Article

References (50)

1. DeLellis R: Atlas of Tumor Pathology: Tumors of the Parathyroid Gland, V2.0. Edited by J Rosai. Washington DC, Armed Forces Institute of Pathology, 1993
2. Marx SJ: Medical progress - hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000, 343:1863-1875
3. Harness JK, Ramsburg SR, Nishiyama RH, Thompson NW: Multiple adenomas of the parathyroids: do they exist? Arch Surg 1979, 114:468-474
4. Roses DF, Karp NS, Sudarsky LA, Valensi QJ, Rosen RJ, Blum M: Primary hyperparathyroidism associated with two enlarged parathyroid glands Arch Surg 1989, 124:1261-1265
5. Attie JN, Bock G, Auguste LJ: Multiple parathyroid adenomas: report of thirty-three cases. Surgery 1990, 108:1014-1019
6. Tezelman S, Shen W, Shaver JK, Siperstein AE, Duh QY, Klein H, Clark OH: Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy Ann Surg 1993, 218:300-307
7. Koshiishi N, Chong JM, Fukasawa T, Ikeno R, Tanaka A, Kanazawa K, Ogura M, Ebuchi M, Takizawa T, Furata N, Fukayama M: Microsatellite instability and loss of heterozygosity in primary and secondary proliferative lesions of the parathyroid gland. Lab Invest 1999, 79:1051-1058
8. Larian B, Alavi S, Roesler J, Namazie A, Blackwell K, Calcaterra TC, Wang MB: The role of hyperplasia in multiple parathyroid adenomas. Head Neck 2001, 23:134-139
9. Williamson C, Pannett AA, Pang JT, Wooding C, McCarthy M, Sheppard MN, Monson J, Clayton RN, Thakker RV: Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36. J Med Genet 1997, 34:617-619
10. Agarwal SK, Schrock E, Kester MB, Burns AL, Heffess CS, Ried T, Marx SJ: Comparative genomic hybridization analysis of human parathyroid tumors. Cancer Genet Cytogenet 1998, 106:30-36
11. Palanisamy N, Imanishi Y, Rao PH, Tahara H, Chaganti RSK, Arnold A: Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J Clin Endocrinol Metab 1998, 83:1766-1770
12. Teh BT, Kytola S, Farnebo F, Bergman L, Wong FK, Weber G, Hayward N, Larsson C, Skogseid B, Beckers A, Phelan C, Edwards M, Epstein M, Alford F, Hurley D, Grimmond S, Silins G, Walters M, Stewart C, Cardinal J, Khodaei S, Parente F, Tranebjaerg L, Jorde R, Menon J, Khir A, Tan TT, Chan SP, Zaini A, Khalid BAK, Sandelin K, Thompson N, Brandi M-L, Warth M, Stock J, Leisti J, Cameron D, Shepherd JJ, Oberg K, Nordenskjold M, Salmela P: Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 1998, 83:2621-2626
13. Farnebo F, Kytola S, Teh BT, Dwight T, Wong FK, Hoog A, Elvius M, Wassif WS, Thompson NW, Farnebo LO, Sandelin K, Larsson C: Alternative genetic pathways in parathyroid tumorigenesis. J Clin Endocrinol Metab 1999, 84:3775-3780
14. Dwight T, Twigg S, Delbridge L, Wong FK, Farnebo F, Richardson AL, Nelson A, Zedenius J, Philips J, Larsson C, Teh BT, Robinson B: Loss of heterozygosity in sporadic parathyroid tumors: involvement of chromosome 1 and the MEN1 gene locus in 11q13 Clin Endocrinol 2000, 53:85-92
15. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmertbuck MR, Debelenko LV, Zhuang ZP, Lubensky IA, Liotta LA, Crabtree JS, Wang YP, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong QH, Spiegel AM, Burns AL, Marx SJ: Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997, 276:404-407
16. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G, Pugeat M, Calender A, Parente F, Quincey D, Gaudray P, De Wit MJ, Lips CJ, Hoppener JW, Khodaei S, Grant AL, Weber G, Kytola S, Teh BT, Farnebo F, Thakker RV. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 1997, 6:1177-1183
17. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmertbuck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang ZP, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ: Somatic mutation of the MEN1 gene in parathyroid tumors. Nat Genet 1997, 16:375-378
18. Carling T, Correa P, Hessman O, Hedberg J, Skogseid B, Lindberg D, Rastad J, Westin G, Åkerström G: Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab 1998, 83:2960-2963
19. Farnebo F, Teh BT, Kytola S, Svensson A, Phelan C, Sandelin K, Thompson NW, Hoog A, Weber G, Farnebo LO, Larsson C: Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 1998, 83:2627-2630
20. Bergman L, Teh B, Cardinal J, Palmer J, Walters M, Shepherd J, Cameron D, Hayward N: Identification of MEN1 gene mutations in families with MEN 1 and related disorders Br J Cancer 2000, 83:1009-1014
21. Karges W, Schaaf L, Dralle H, Boehm BO: Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1). Exp Clin Endocrinol Diabetes 2000, 108:334-340
22. Uchino S, Noguchi S, Sato M, Yamashita H, Watanabe S, Murakami T, Toda M, Ohshima A, Futata T, Mizukoshi T, Koike E, Takatsu K, Terao K, Wakiya S, Nagatomo M, Adachi M: Screening of the MEN1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 2000, 60:5553-5557
23. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmertbuck MR, Skarulis MC, Doppman JL, Kim YS, Lubensky IA, Zhuang ZP, Green JS, Guru SC, Manickam P, Olufemi SE, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ: Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997, 6:1169-1175
24. Bartsch D, Kopp I, Bergenfelz A, Rieder H, Munch K, Jager K, Deiss Y, Schudy A, Barth P, Arnold R, Rothmund M, Simon B: MEN1 gene mutations in 12 MEN1 families and their associated tumors. Eur J Endocrinol 1998, 139:416-420
25. Roijers JFM, de Wit MJ, van der Luijt RB, van Amstel HKP, Hoppener JWM, Lips CJM: Criteria for mutation analysis in MEN 1-suspected patients: mEN 1 case-finding. Eur J Clin Invest 2000, 30:487-492
26. Clark OH, Way LW, Hunt TK: Recurrent hyperparathyroidism. Ann Surg 1976, 184:391-402
27. Wadstrom C, Zedenius J, Guinea A, Reeve TS, Delbridge L: Reoperative surgery for recurrent or persistent primary hyperparathyroidism. Aust N Z J Surg 1998, 68:103-107
28. Mathew CG, Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ, Ponder BA: Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 1987, 328:524-526
29. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J: A comprehensive genetic map of the human genome based on 5, 264 microsatellites. Nature 1996, 380:152-154
30. Manickam P, Guru SC, Debelenko LV, Agarwal SK, Olufemi SE, Weisemann JM, Boguski MS, Crabtree JS, Wang YP, Roe BA, Lubensky IA, Zhuang ZP, Kester MB, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Emmertbuck MR, Collins FS, Chandrasekharappa SC: Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region. Hum Genet 1997, 101:102-108
31. Farnebo F, Teh BT, Dotzenrath C, Wassif WS, Svensson A, White I, Betz R, Goretzki P, Sandelin K, Farnebo LO, Larsson C: Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism. Hum Genet 1997, 99:342-349
32. Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM: Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 2000, 88:2739-2750
33. Jeck T, Weisser B, Mengden T, Erdmenger L, Grune S, Vetter W: Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands. Clin Invest 1994, 72:979-984
34. Kytola S, Farnebo F, Obara T, Isola J, Grimelius L, Farnebo LO, Sandelin K, Larsson C: Patterns of chromosomal imbalances in parathyroid carcinomas. Am J Pathol 2000, 157:579-586
35. Dwight T, Kytola S, Teh BT, Theodosopoulos G, Richardson AL, Philips J, Twigg S, Delbridge L, Marsh DJ, Nelson AE, Larsson C, Robinson BG: Genetic analysis of lithium-associated parathyroid tumors. Eur J Endocrinol 2002, 146:619-627
36. Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A: Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosom Cancer 1995, 13:9-17
37. Benn DE, Dwight T, Richardson AL, Delbridge L, Bambach CP, Stowasser M, Gordon RD, Marsh DJ, Robinson BG: Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. Cancer Res 2000, 60:7048-7051
38. Sippel KC, Fraioli RE, Smith GD, Schalkoff ME, Sutherland J, Gallie BL, Dryia TP: Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. Am J Hum Genet 1998, 62:610-619
39. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC: Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993, 366:575-580
40. Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG: Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypocalcaemia and neonatal severe hyperparathyroidism. Cell 1993, 75:1297-1303
41. Hosokawa Y, Pollak MR, Brown EM, Arnold A: Mutational analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 1995, 80:3107-3110
42. Cetani F, Pinchera A, Pardi E, Cianferotti L, Vignali E, Picone A, Miccoli P, Viacava P, Marcocci C: No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J Bone Miner Res 1999, 14:878-882
43. Farnebo F, Enberg U, Grimelius L, Backdahl M, Schalling M, Larsson C, Farnebo LO: Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab 1997, 82:3481-3486
44. Farnebo F, Hoog A, Sandelin K, Larsson C, Farnebo LO: Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas. Surgery 1998, 124:1094-1098
45. Cetani F, Picone A, Cerrai P, Vignali E, Borsari S, Pardi E, Viacava P, Naccarato AG, Miccoli P, Kifor O, Brown EM, Pinchera A, Marcocci C: Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca2+ set-point in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85:4789-4794
46. Heath H, Jackson CE, Otterud B, Leppert MF: Genetic linkage analysis in familial benign (hypocalciuric) hypocalcaemia: evidence for locus heterogeneity. Am J Hum Genet 1993, 53:193-200
47. Lloyd SE, Pannett AA, Dixon PH, Whyte MP, Thakker RV: Localization of familial benign hypocalcaemia, Oklahoma variant (FBHOk), to chromosome 19q13. Am J Hum Genet 1999, 64:189-195
48. Yuan Y, Mendez R, Sahin A, Dai JL: Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 2001, 61:5558-5561
49. Nakayama T, Watanabe M, Suzuki H, Toyota M, Sekita N, Hirokawa Y, Mizokami A, Ito H, Yatani R, Shiraishi T: Epigenetic regulation of androgen receptor gene expression in human prostate cancers. Lab Invest 2000, 80:1789-1796
50. Juppner H, Brown EM, Kronenberg HM: Parathyroid hormone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Edited by MJ Favus. Sydney, Lippincott Williams and Wilkins, 1999, pp 80-87